Potential Utility of Therapeutic Drug Monitoring of Adalimumab in Predicting Short-Term Mucosal Healing and Histologic Remission in Pediatric Crohn's Disease Patients
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.